Why 23andMe Stock Dropped Today
Shares of 23andMe Holding (NASDAQ: ME) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and pharmacy services platform Lemonaid Health (not to be confused with Lemonade (NYSE: LMND), the insurance provider).
As of 11 a.m. EDT, 23andMe shares are down 4.2%. (But coincidentally, Lemonade is down even more.)
Image source: Getty Images.
Source Fool.com
